SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
POST EFFECTIVE AMENDMENT NO. 3
TO
FORM SB-2
Registration Statement under
the Securities Act of 1933
NEUROBIOLOGICAL TECHNOLOGIES, INC.
(Exact name of small business issuer as specified in its charter)
Delaware 2836 94-3049219
(State of (Primary Standard Industrial (IRS Employer
incorporation) Classification Code) Identification Number)
JEFFREY S. PRICE, Ph.D.
President and Chief Executive Officer
NEUROBIOLOGICAL TECHNOLOGIES, INC.
1387 Marina Way South
Richmond, California 94804
(510) 215-8000
(name, address, including zip code, and telephone number
including area code, of registrant's principal offices)
Copies to:
Thomas E. Sparks, Jr.
John L. Donahue
Pillsbury, Madison & Sutro LLP
P.O. Box 7880
San Francisco, California 94120
Approximate date of commencement of proposed sale to the public:
From time to time after this Registration Statement becomes effective.
If this form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, please check the following box and list
the Securities Act registration number of the earlier effective registration
statement for the same offering.
<PAGE>
If this Form is a post-effective amendment filed pursuant to Rule 462 (c) under
the Securities Act, check the following box and list the Securities Act
registration number of the earlier effective registration statement for the same
offering.
If the delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box.
The Registrant hereby amends this Registration Statement on such date or dates
as may be necessary to delay its effective date until the Registrant shall file
a further amendment which specifically states that this Registration Statement
shall thereafter become effective in accordance with Section 8(a) of the
Securities Act of 1933 or until the Registration Statement shall become
effective on such date as the Commission, acting pursuant to said Section 8(a),
may determine.
<PAGE>
The Registrant hereby withdraws from registration under this Registration
Statement 230,000 shares of Common Stock, $.01 par value. Such shares were
unsold at the termination of the offering covered by these Registration
Statements.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form SB-2, and has duly caused this Amendment to
Registration Statement to be signed on its behalf by the undersigned, t hereunto
duly authorized, in the City of Richmond, State of California, on May 16, 1996.
NEUROBIOLOGICAL TECHNOLOGIES, INC.
By /s/ JEFFREY S. PRICE
Jeffrey S. Price
President and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this Amendment to
Registration Statement has been signed below by the following persons in the
capacities and on the dates indicated.
Name Title Date
/s/ JEFFREY S. PRICE President, Chief Executive Officer May 16, 1996
(Principal Executive Officer) and
Director
/s/ MICHAEL S. OSTRACH Executive Vice President, Chief May 16, 1996
Operating Officer and Director
(Principal Financial Officer)
/s/ SHAWN K. JOHNSON Director of Finance May 16, 1996
(Principal Accounting Officer)
/s/ ABRAHAM E. COHEN Chairman of the Board May 16, 1996
/s/ ENOCH CALLAWAY Director May 16, 1996
/s/ THEODORE L. ELIOT, Jr. Director May 16, 1996
/s/ LAWRENCE G. MOHR, Jr. Director May 16, 1996
/s/ JOHN B. STUPPIN Director May 16, 1996
*By JEFFREY S. PRICE
Jeffrey S. Price
